Dehydroepiandrosterone Sulfotransferase Is a Target for Transcriptional Induction by the Vitamin D Receptor

Molecular Pharmacology

Volumn 65, Issue 3, 2004, Pages 720-729

  Echchgadda, Ibtissam ^a   Song, Chung S ^a   Roy, Arun K ^a   Chatterjee, Bandana ^a,b  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^b SOUTH TEXAS VETERANS HEALTH CARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BILE ACID; CALCITRIOL; CYTOCHROME P450; DEOXYRIBONUCLEASE I; FARNESOID X RECEPTOR; HYDROXYSTEROID SULFOTRANSFERASE; PRASTERONE; PRASTERONE SULFOTRANSFERASE; PREGNANE X RECEPTOR; RETINOID X RECEPTOR; TESTOSTERONE; THYMIDINE KINASE; UNCLASSIFIED DRUG; VITAMIN D RECEPTOR;

ANIMAL CELL; ARTICLE; BINDING SITE; CONTROLLED STUDY; DNA FOOTPRINTING; GEL MOBILITY SHIFT ASSAY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; INTESTINE CELL; INVERTED REPEAT; LIVER CELL; MOUSE; NONHUMAN; POINT MUTATION; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; RAT; REPORTER GENE; STEROID METABOLISM; SULFONATION; TRANSCRIPTION REGULATION; XENOBIOTIC METABOLISM;

BASE SEQUENCE; DNA FOOTPRINTING; GENE EXPRESSION; GENE EXPRESSION REGULATION; HUMANS; MOLECULAR SEQUENCE DATA; PROMOTER REGIONS (GENETICS); RECEPTORS, CALCITRIOL; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RECEPTORS, STEROID; SEQUENCE HOMOLOGY, NUCLEIC ACID; SULFOTRANSFERASES; TRANSFECTION; TUMOR CELLS, CULTURED; VITAMIN D;

EID: 1342265781     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: 10.1124/mol.65.3.720     Document Type: Article

References (40)

1. Brodie MJ, Boobis AR, Hillyard CJ, Abeyasekera G, Stevenson JC, MacIntyre I, and Park BK (1982) Effect of rifampicin and isoniazid on vitamin D metabolism. Clin Pharmacol Ther 32:525-530.
2. Chatelain G, Brun G, and Michel D (1995) Screening of homozygous transgenic mice by comparative PCR. Biotechniques 18:958-960.
3. Cowen AE, Korman MG, Hofmann AF, and Cass OW (1975) Metabolism of lithocholate in healthy man. I. Biotransformation and biliary excretion of intravenously administered lithocholate, lithocholylglycine and their sulfates. Gastroenterology 69:59-66.
4. D'Erasmo E, Ragno A, Raejntroph N, Pisani D (1998) Drug-induced osteomalacia. Recent Prog Med 89:529-533.
5. Drocourt L, Ourlin JC, Pascussi JM, Maurel P, and Vilarem MJ (2002) Expression of CYP3A4, CYP2B6 and CYP2C9 is regulated by the vitamin D receptor pathway in primary human hepatocytes. J Biol Chem 277:25125-25132.
6. Echchgadda I, Song CS, Mubiru JN, Roy AK, and Chatterjee B (2002) Pregnane X receptor is an activator of the DHEA-sulfotransferase gene (Abstract). Proceedings of the 84th Annual Meeting of the Endocrine Society; 2002 June 19-22; San Francisco, CA.
7. Echchgadda I, Song CS, Roy AK, and Chatterjee B (2003) Xenobiotic induction of human-sulfotransferase gene transcription: role of the xenosensing pregnane X receptor (PXR) and constitutive androstane receptor (CAR) (Abstract). Proceedings of the 85th Annual Meeting of the Endocrine Society; 2003 June 19-22; Philadelphia, PA.
8. Falany CN (1997) Enzymology of human cytosolic sulfotransferases. FASEB J 11:206-216.
9. Goodwin B, Redinbo MR, Kliewer SA (2002) Regulation of cyp3a gene transcription by the pregnane X receptor. Annu Rev Pharmacol Toxicol 42:1-23.
10. Guyton KZ, Kensler TW, and Posner GH (2001) Cancer chemoprevention using natural vitamin D and synthetic analogs. Annu Rev Pharmacol Toxicol 41:421-442.
11. Hofmann AF (1994) Microtubule-dependent transport of bile salts through hepatocytes: cholic vs. taurocholatic acid. Hepatology 20:1375-1378.
12. Honkakoski P, Sueyoshi T, and Negishi M (2003) Drug-activated nuclear receptors CAR and PXR. Ann Med 35:172-182.
13. Jurukuta PW, MacDonald PN, Nakajima S, Hsieh JC, Thompson PD, Whitfield GY, Galligan MA, Haussler CA, and Haussler MR (2002) Isolation of baculovirus-expressed human vitamin D receptor: DNA responsive element interactions and phosphorylation of the purified receptor. J Cell Biochem 85:435-457.
14. Kitada H, Miyata M, Nakamura T, Tozawa A, Honma W, Shimada M, Nagata K, Sinal CJ, Guo GL, Gonzalez FJ, et al. (2003) Protective role of hydroxysteroid sulfotransferase in lithocholic acid-induced liver toxicity. J Biol Chem 278:17838-17844.
15. Klaassen CD and Boles JW (1997) Sulfation and sulfotransferases 5: the importance of 3′-phosphoadenosine 5′-phosphosulfate (PAPS) in the regulation of sulfation. FASEB J 11:404-418.
16. Kong AN and Fei P (1994) Molecular cloning of three sulfotransferase cDNAs from mouse liver. Chem Biol Interact 92:161-168.
17. Makishima M, Lu TT, Xie W, Whitfield GK, Domoto H, Evans RM, Haussler MR, and Mangelsdorf DJ (2002) Vitamin D receptor as an intestinal bile acid sensor. Science (Wash DC) 296:1313-1316.
18. Meloche CA, Sharma V, Swedmark S, Andersson P, and Falany CN (2002) Sulfation of budesonide by human cytosolic sulfotransferase, dehydroepiandrosterone-sulfotransferase (DHEA-ST). Drug Metab Dispos 30:582-585.
19. Mulder GJ and Jakoby WB (1990) Sulfation, in Conjugation Reactions in Drug Metabolism: An Integrated Approach: Substrates, Co-Substrates, Enzymes and Their Interactions in Vivo and in Vitro (Mulder GJ ed) pp 107-161, Taylor and Francis, London.
20. Norman AW (1990) Intestinal calcium absorption: a vitamin D-hormone-mediated adaptive response. Am J Clin Nutr 51:290-300.
21. Otterness DM, Wieben ED, Wood TC, Watson WG, Madden BJ, McCormick DJ, and Weinshilboum RM (1992) Human liver dehydroepiandrosterone sulfotransferase: molecular cloning and expression of cDNA. Mol Pharmacol 41:865-872.
22. Pai TG, Sugahara T, Suiko M, Sakakibara Y, Xu F, and Liu MC (2002) Differential xenoestrogen-sulfating activities of the human cytosolic sulfotransferases: molecular cloning, expression and purification of human SULT2B1a and SULT2B1b sulfotransferases. Biochim Biophys Acta 1573:165-170.
23. Peet DJ, Janowski BA, Mangelsdorf DJ (1998) The LXRs: a new class of oxysterol receptors. Curr Opin Genet Dev 8:571-575.
24. Runge-Morris M, Wu W, and Kocarek TA (1999) Regulation of rat hepatic hydroxysteroid sulfotransferase (SULT2-40/41) gene expression by glucocorticoids: evidence for a dual mechanism of transcriptional control. Mol Pharmacol 56:1198-1206.
25. Schmiedlin-Ren P, Thummel KE, Fisher JM, Paine MF, and Watkins PB (2001) Induction of CYP3A4 by 1α, 25-dihydroxyvitamin D3 is human cell line-specific and is unlikely to involve pregnane X receptor. Drug Metab Dispos 29:1446-1453.
26. Schuetz EG, Strom S, Yasuda K, Lecureur V, Assem M, Brimer C, Lamba J, Kim RB, Ramachandran V, Komoroski BJ, et al. (2001) Disrupted bile acid homeostasis reveals an unexpected interaction among nuclear hormone receptors, transporters and cytochrome P450. J Biol Chem 276:39411-39418.
27. Shibutani S, Shaw PM, Suzuki N, Dasaradhi L, Duffel MW, and Terashima I (1998) Sulfation of alpha-hydroxytamoxifen catalyzed by human hydroxysteroid sulfotransferase results in tamoxifen-DNA adducts. Carcinogenesis 19:2007-2011.
28. Shimada M, Yoshinari K, Tanabe E, Shimakawa E, Kobashi M, Nagata K, and Yamazoe Y (2001) Identification of ST2A1 as a rat brain neurosteroid sulfotransferase mRNA. Brain Res 920:222-225.
29. Song CS, Kim JM, Roy AK, and Chatterjee B (1990) Structure and regulation of the senescence marker protein 2 gene promoter. Biochemistry 29:542-551.
30. Song CS, Jung MH, Kim SC, Hassan T, Roy AK, and Chatterjee B (1998) Tissue-specific and androgen-repressible regulation of the rat dehydroepiandrosterone sulfotransferase gene promoter. J Biol Chem 273:21856-21866.
31. Song CS, Echchgadda I, Baek BS, Ahn SC, Oh T, Roy AK, and Chatterjee B (2001) Dehydroepiandrosterone sulfotransferase gene induction by bile acid activated farnesoid X receptor. J Biol Chem 276:42549-42556.
32. Sonoda J, Xie W, Rosenfeld JM, Barwick JL, Guzelian PS, and Evans RM (2002) Regulation of a xenobiotic sulfonation cascade by nuclear pregnane X receptor (PXR). Proc Natl Acad Sci USA 99:13801-13816.
33. Strott CA (2002) Sulfonation and molecular action. Endocr Rev 23:703-732.
34. Thomae BA, Eckloff BW, Freimuth RR, Wieben ED, and Weinshilboum RM (2002) Human sulfotransferase SULT2A1 pharmacogenetics: genotype-to-phenotype studies. Pharmacogenomics J 2:48-56.
35. Thompson PD, Jurutka PW, Whitfield GK, Myskowski SM, Eichhorst KR, Dominguez CE, Haussler CA, and Haussler MR (2002) Liganded VDR induces CYP3A4 in small intestinal and colon cancer cells via DR3 and ER6 vitamin D responsive elements. Biochim Biophys Res Commun 299:730-738.
36. Thummel KE, Brimer C, Yasuda K, Thottassery J, Senn T, Lin Y, Ishizuka H, Kharasch E, Schuetz J, and Schuetz E (2001) Transcriptional control of intestinal cytochrome P-4503A by 1α,25-dihydroxy vitamin D3. Mol Pharmacol 60:1399-1406.
37. Toell A, Polly P, and Carlberg C (2000) All natural DR3-type vitamin D response elements show a similar functionality in vitro. Biochem J 352:301-309.
38. Weinshilboum RM, Otterness DM, Aksoy IA, Wood TC, Her C, and Raftogianis RB (1997) Sulfation and sulfotransferases 1: Sulfotransferase molecular biology: cDNAs and genes. FASEB J 11:3-14.
39. Willson TM and Kliewer SA (2002) PXR, CAR and drug metabolism. Nat Rev Drug Discov 1:259-266.
40. Yu J, Lo JL, Huang L, Zhao A, Metzger E, Adams A, Meinke T, Wright SD, and Cui J (2002) Lithocholic acid decreases expression of bile salt export pump through farnesoid X receptor antagonist activity. J Biol Chem 277:31441-31447.